Ignite Creation Date:
2024-05-05 @ 5:08 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00390845
Status:
COMPLETED
Last Update Posted:
2017-08-22
First Post:
2006-10-18
Brief Title:
P38 Mitogen-activated Protein Map Kinase Inhibitor SB-681323Study In Patients With Neuropathic Pain
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-08-30
Start Date Type:
ACTUAL
Primary Completion Date:
2008-08-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-08-11
Completion Date Type:
ACTUAL
First Submit Date:
2006-10-18
First Submit QC Date:
October 18 2006
Study First Post Date:
2006-10-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2009-07-22
Disp First Submit QC Date:
July 22 2009
Disp First Post Date:
2009-08-10
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2017-08-21
Last Update Post Date:
2017-08-22
Last Update Post Date Type:
ACTUAL